Impact of PARP inhibitor expanded access program on the uptake of genetic testing in newly diagnosed or recurrent ovarian cancer patients in Singapore
Ong, P.Y., Tan, D.S., Aung, K.Z., Er, J.B.T., Lee, S.C.Volume:
145
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.03.181
Date:
June, 2017
File:
PDF, 129 KB
english, 2017